Key Laboratory of Analytical Chemistry for Biology and Medicine, Ministry of Education, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China.
Neuropharmacology. 2011 Feb-Mar;60(2-3):252-8. doi: 10.1016/j.neuropharm.2010.09.005. Epub 2010 Sep 22.
In this study, we investigated whether resveratrol could protect against ischemic injury by improving brain energy metabolism and alleviating oxidative stress. Male rats were divided into three groups: sham operation, ischemia treatment, and ischemia combined with resveratrol treatment (resveratrol-treated group, 30 mg/kg intraperitoneally for 7 days). Cerebral ischemia was induced by using the model of middle cerebral artery occlusion. The dialysates in hypothalamus were obtained by brain microdialysis technique. The effects of resveratrol on neurologic functions and histopathologic changes were evaluated. The levels of ATP, ADP, AMP, adenosine, inosine, hypoxanthine and xanthine in microdialysate were monitored by HPLC analysis. The levels of malondialdehyde and the activities of xanthine oxidase in brain tissues were analyzed in three groups. This study shows that the ischemic infarcts were significantly reduced and neurological functions were improved in resveratrol-treated group compared to ischemia group. The analysis results show that resveratrol treatments remarkably enhanced the level of glucose, ATP and energy charge; decreased the levels of lactate during I/R period. Resveratrol treatments significantly increased the basal levels of adesonine and inosine, inhibited the elevations of hypoxanthine and xanthine levels and remarkably decreased xanthine oxidase activity and malondialdehyde levels. This study provides in vivo evidence that resveratrol could exert neuroprotective effect against ischemia injury by improving brain energy metabolism and alleviating oxidative stress via inhibiting xanthine oxidase activity and preventing the production of hypoxanthine, xanthine and oxygen radicals during ischemia/reperfusion.
在这项研究中,我们研究了白藜芦醇是否可以通过改善脑能量代谢和减轻氧化应激来保护缺血性损伤。雄性大鼠分为三组:假手术组、缺血处理组和缺血联合白藜芦醇处理组(白藜芦醇处理组,30mg/kg 腹腔内注射 7 天)。采用大脑中动脉闭塞模型诱导脑缺血。通过脑微透析技术获得下丘脑透析液。评估白藜芦醇对神经功能和组织病理学变化的影响。通过 HPLC 分析监测微透析液中 ATP、ADP、AMP、腺苷、肌苷、次黄嘌呤和黄嘌呤的水平。分析三组脑组织中丙二醛和黄嘌呤氧化酶的活性。本研究表明,与缺血组相比,白藜芦醇处理组的缺血性梗死明显减少,神经功能得到改善。分析结果表明,白藜芦醇处理可显著提高葡萄糖、ATP 和能量电荷水平;在 I/R 期间降低乳酸水平。白藜芦醇处理可显著提高腺苷和肌苷的基础水平,抑制次黄嘌呤和黄嘌呤水平的升高,并显著降低黄嘌呤氧化酶活性和丙二醛水平。本研究提供了体内证据,表明白藜芦醇通过抑制黄嘌呤氧化酶活性和防止缺血/再灌注期间次黄嘌呤、黄嘌呤和氧自由基的产生,可通过改善脑能量代谢和减轻氧化应激来发挥对缺血性损伤的神经保护作用。